VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 712 filers reported holding VANECK VECTORS ETF TR in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,894 | -9.5% | 1,074 | +1.2% | 0.00% | – |
| Q2 2023 | $31,939 | -36.7% | 1,061 | -32.0% | 0.00% | -100.0% |
| Q1 2023 | $50,490 | +36.0% | 1,561 | +20.5% | 0.00% | – |
| Q4 2022 | $37,115 | +19.7% | 1,295 | 0.0% | 0.00% | – |
| Q3 2022 | $31,000 | +40.9% | 1,295 | +62.9% | 0.00% | – |
| Q2 2022 | $22,000 | -51.1% | 795 | -32.7% | 0.00% | -100.0% |
| Q1 2022 | $45,000 | -38.4% | 1,181 | -48.3% | 0.00% | 0.0% |
| Q4 2021 | $73,000 | +9.0% | 2,284 | +0.7% | 0.00% | 0.0% |
| Q3 2021 | $67,000 | -13.0% | 2,267 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $77,000 | +14.9% | 2,267 | +9.7% | 0.00% | 0.0% |
| Q1 2021 | $67,000 | -5.6% | 2,067 | +4.3% | 0.00% | -50.0% |
| Q4 2020 | $71,000 | – | 1,981 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |